Breast/lung cancer
11 – 20 of 35
                - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
        Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        The DNA methylation landscape of primary triple-negative breast cancer
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden : A Nationwide Registry Analysis from the I-O Optimise Initiative
    
    - Contribution to journal › Article
 
- 
                        Mark
        Decoding pan-cancer complexity. Multiomic insights from the lung and breast
    (2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Kataegis in clinical and molecular subgroups of primary breast cancer
    (2024) European Association for Cancer Research- Contribution to conference › Poster
 
- 
                        Mark
        Kataegis in clinical and molecular subgroups of primary breast cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC) : a pooled analysis of seven studies
    
    - Contribution to journal › Article
 
- 
                        Mark
        Current and emerging sequencing-based tools for precision cancer medicine
    
    - Contribution to journal › Scientific review
 
